Valion Bio, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-1.2M | $1.0M |
| FY2021 | — | $13.3M | $13.0M |
| FY2022 | — | $3.6M | $3.5M |
| FY2023 | — | $3.6M | $3.4M |
| FY2024 | — | $2.5M | $2.0M |
| FY2025 | — | $3.3M | $12.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-1.2M | $1.0M |
| FY2021 | — | $13.3M | $13.0M |
| FY2022 | — | $3.6M | $3.5M |
| FY2023 | — | $3.6M | $3.4M |
| FY2024 | — | $2.5M | $2.0M |
| FY2025 | — | $3.3M | $12.6M |